Your Catalyst To a Lucrative Business
On the basis of applications , the global genomics industry is divided into academic research , drug discovery , diagnostics , personalized medicine , and others . Diagnostics held the highest market share in 2013 . Preference for molecular diagnostics tests and awareness among medical practitioners about the advantages of geneticbased diagnostics are factors that propel this segment . It is expected that personalized medicine will register a high growth rate throughout the forecast period . Treatment optimization , affordable treatments , patient compliance , early disease prognosis , and drug safety are vital drivers of this segment . North America emerged a global leader in the market for personalized medicine in 2013 . This was due to progress in the world of genetics and robust technological developments .
As per technologies , the industry is segmented as DNA microarray , nucleic acid extraction & purification , PC R ( polymerase chain reaction ), and DNA sequencing . PCR led the market in 2013 due to factors , such as R & D in genomics & proteomics , encouraging government policies on R & D funding , and technological advancements . Ongoing industry trends suggest that the nucleic acid extraction & purification segment may grow at a CAGR exceeding 10 % till 2024 .
Europe , Asia Pacific , North America , and Rest of the World are the four regional segments of the global Genomics Industry . Prevalence of cardiovascular & genetic disorders and high investments in genomics & proteomics drive the Europe genomics market . This region held the largest industry share in 2013 . However , volatile economic conditions and uneven reimbursement policies may hamper regional growth in the forthcoming years .
Asia Pacific is expected to grow rapidly over the forecast period because of widespread adoption of genomics techniques in emerging countries , such as China and India . These regions utilize genomics technologies to diagnose & treat diseases , like cancer and diabetes . Other factors that fuel the Asia Pacific region are surging medical expenditure , high disposable incomes , and better healthcare infrastructure . Key players in the global genomics market are Life Technologies , Roche Diagnostics , GE Healthcare , Agilent Technologies , and Cepheid . Researchers have developed a microscope that uses a cell phone camera for detecting fluorescent components of DNA sequencing responses in tissues & cells . This special device can identify point mutations in KRAS genes . The KRAS gene is found in more than thirty percent of colon cancers . A number of sequencing techniques are used to fluorescently label & amplify copies of the target DNA transcript or sequence .
Browse Related Category Market Reports @ https :// www . hexaresearch . com / researchcategory / biotechnology-industry
Follow Us :